
How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio.

Ndimuangu Nchotou Hilton is a senior clinical research associate with extensive experience in clinical research, including the monitoring and management of clinical trials across multiple therapeutic areas. Throughout his career, Hilton has contributed to Phase I–IV studies, with a strong focus on ensuring data integrity, safeguarding patient safety, and supporting the conduct of research in compliance.

How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio.